Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Its oral small-molecule design improves accessibility and patient compliance compared to injectables
Its phase 2 data, published in the New England Journal of Medicine in 2023, showed about 24% weight loss at the highest dose over 48 weeks, and later phase 3 results pushed toward 28%
IGF-1 also reduces inflammation in the damaged areas, enhancing the activity of cells involved in tissue renewal (Yakar et al., 2019)
Morley JE, Argiles JM, Evans WJ, Bhasin S, Cella D, Deutz NE, Doehner W, Fearon KC, Ferrucci L, Hellerstein MK, Kalantar-Zadeh K, Lochs H, MacDonald N, Mulligan K, Muscaritoli M, Ponikowski P, Posthauer ME, Rossi FF, Schambelan M, Schols AM, Schuster MW, Anker SD
Regenerative protein thymosin beta-4 is a novel regulator of purinergic signaling
The genetic test reveals predispositions in peptide genetic pathways related to appetite regulation and metabolic control
US$ 24.11
US$ 29.04
US$ 21.38
US$ 28.08
US$ 21.61
US$ 27.32
US$ 23.15
US$ 25.21
US$ 24.47
US$ 22.05
